MedPath

The effect of Bumethanide treatment on seizure controlling in patients with drug resistance temporal lobe epilepsies candidate for surgery

Phase 1
Conditions
Temporal Lobe Epilepsy.
other epilepsy
Registration Number
IRCT201012115368N1
Lead Sponsor
Cellular and Molecular Research Center of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Inclusion: 1) Suffering from drug resistance temporal lobe epilepsy 2) Candidate for temporal lobectomy 3) Giving informed consent.
Exclusion: Contraindication for Bumethanide

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Seizure occurrence. Timepoint: 1 month before and 1 month after intervention. Method of measurement: EEG.
Secondary Outcome Measures
NameTimeMethod
Dose reduction of anti-epileptic drugs. Timepoint: 3 months before and 3 months after intervention. Method of measurement: dosage.
© Copyright 2025. All Rights Reserved by MedPath